This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Dosing anticancer drugs by body surface area was first introduced in the 1950s, based on preclinical animal models. The rationale was that this metric would better correlate with drug pharmacokinetics and organ function than weight-based dosing. But is it still appropriate in oncology practice today? Professor Alain Astier explains. Body surface area (BSA), calculated using height and weight and expressed in square metres (m), was thought to provide a universal dosing metric applicable across di
In a study comparing the performance of multiple trigger tools in identifying medication-related hospital readmissions, the OPERAM tool performed the best, identifying the highest number of both the total medication-related (re)admissions (MRRs) and potential preventable MRRs. Trigger tools are used to identify and measure adverse events over time and recognise MRRs.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Prime Therapeutics, a PBM owned by Blue Cross plans, violated federal and state antitrust laws through a collaboration with Express Scripts and must pay AIDS Healthcare Foundation more than $10 million, an arbitrator ruled.
While the year's 57 Chapter 11 filings didn't reach the highs of 2023, physician practice bankruptcies continue to trend up while hospitals saw their largest bankruptcy "by far in the last 30 years.
While the year's 57 Chapter 11 filings didn't reach the highs of 2023, physician practice bankruptcies continue to trend up while hospitals saw their largest bankruptcy "by far in the last 30 years.
Memantine/donepezil and everolimus are used to treat dementia of the Alzheimer type and tuberous sclerosis complex-associated subependymal giant cell astrocytoma, respectively.
Anti-tau candidates haven’t crossed the regulatory threshold like their anti-amyloid counterparts, but J&J’s clinical efforts could lead in the right direction.
Elevance Health posted $418 million in profit for the fourth quarter of 2024, a figure that surpassed Wall Street's expectations despite decreasing 51% year over year.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We’ve got lots of news coming out of D.C. today — let’s get straight into it.
More than 24 million people secured coverage during open enrollment on the Affordable Care Act's exchanges, according to the latest marketplace report from CMS.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Centivo, a self-funded health plan for employers, is scaling its virtual care offerings following its acquisition of Eden Health. The company says more members are taking advantage of virtual primary care.
London-based Neko Health picked up $260 million in fresh funding for its full-body scanning technology, while Solera Health nabbed $40 million and startup Percipio Health launched with $20 million to scale up its smartphone-based population health analytics solution.
The venture builder inked a partnership with Sanabil Investments to open the Sanabil Venture Studio by Redesign Health. The partnership aims to jointly develop and launch at least 20 healthcare companies in the kingdom.
Award winners by category DELIVERY AND DEVICE INNOVATION SHL Medical for Elexy reusable electromechanical autoinjector ECO-DESIGN WINNER Huhtamaki for Omnilock Ultra PAPER PACKAGING INNOVATION WINNER Mitsubishi Gas Chemical Company for new OXYCAPT Multilayer Plastic Vial PATIENT-CENTRIC DESIGN WINNER UCB Pharma for Bimzelx 160mg 2ml autoinjectors product for US START-UP INITIATION WINNER Active Label for non-electric […] The post Pharmapack Award Winners 2025 redefining pharmaceutical pack
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content